Cordlife Group 주식 주식분석 | 주식가격 | 뉴스 | P8A.SI | SG2E64980112 | A1JWVR

날짜	Cordlife Group 주식 가격
	0.15 undefined
	0.15 undefined
	0.15 undefined
	0.15 undefined
	0.15 undefined
	0.16 undefined
	0.16 undefined
	0.16 undefined
	0.16 undefined
	0.15 undefined
	0.15 undefined
	0.15 undefined

날짜	Cordlife Group 매출	Cordlife Group EBIT	Cordlife Group 이익
2023	55.73 백만 undefined	-440,000 undefined	3.52 백만 undefined
2022	55.16 백만 undefined	1.51 백만 undefined	4.89 백만 undefined
2021	56.67 백만 undefined	4.9 백만 undefined	6.14 백만 undefined
2020	50.62 백만 undefined	-5.5 백만 undefined	6.55 백만 undefined
2019	61.58 백만 undefined	-2.93 백만 undefined	6.47 백만 undefined
2018	105.01 백만 undefined	5.5 백만 undefined	5.53 백만 undefined
2017	59.96 백만 undefined	824,000 undefined	-2.57 백만 undefined
2016	59.63 백만 undefined	1.66 백만 undefined	12.33 백만 undefined
2015	57.58 백만 undefined	5.83 백만 undefined	32.46 백만 undefined
2014	49.09 백만 undefined	9.01 백만 undefined	30.52 백만 undefined
2013	34.7 백만 undefined	7.4 백만 undefined	13.5 백만 undefined
2012	30.3 백만 undefined	5.6 백만 undefined	6.9 백만 undefined
2011	25.7 백만 undefined	7.2 백만 undefined	8.5 백만 undefined
2010	28.2 백만 undefined	8.4 백만 undefined	8.3 백만 undefined
2009	22.6 백만 undefined	7.1 백만 undefined	6.2 백만 undefined

	매출	EBIT	이익
2009	22.6 백만 SGD	7.1 백만 SGD	6.2 백만 SGD
2010	28.2 백만 SGD	8.4 백만 SGD	8.3 백만 SGD
2011	25.7 백만 SGD	7.2 백만 SGD	8.5 백만 SGD
2012	30.3 백만 SGD	5.6 백만 SGD	6.9 백만 SGD
2013	34.7 백만 SGD	7.4 백만 SGD	13.5 백만 SGD
2014	49.09 백만 SGD	9.01 백만 SGD	30.52 백만 SGD
2015	57.58 백만 SGD	5.83 백만 SGD	32.46 백만 SGD
2016	59.63 백만 SGD	1.66 백만 SGD	12.33 백만 SGD
2017	59.96 백만 SGD	824,000 SGD	-2.57 백만 SGD
2018	105.01 백만 SGD	5.5 백만 SGD	5.53 백만 SGD
2019	61.58 백만 SGD	-2.93 백만 SGD	6.47 백만 SGD
2020	50.62 백만 SGD	-5.5 백만 SGD	6.55 백만 SGD
2021	56.67 백만 SGD	4.9 백만 SGD	6.14 백만 SGD
2022	55.16 백만 SGD	1.51 백만 SGD	4.89 백만 SGD
2023	55.73 백만 SGD	-440,000 SGD	3.52 백만 SGD

2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
22	28	25	30	34	49	57	59	59	105	61	50	56	55	55
-	27.27	-10.71	20.00	13.33	44.12	16.33	3.51	-	77.97	-41.90	-18.03	12.00	-1.79	-
72.73	71.43	72.00	70.00	73.53	69.39	70.18	66.10	64.41	67.62	63.93	62.00	69.64	67.27	67.27
16	20	18	21	25	34	40	39	38	71	39	31	39	37	37
6	8	8	6	13	30	32	12	-2	5	6	6	6	4	3
-	33.33	-	-25.00	116.67	130.77	6.67	-62.50	-116.67	-350.00	20.00	-	-	-33.33	-25.00
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
210.9	210.9	210.9	171.7	232.6	256.59	260.34	259.77	259.37	254.29	254.63	256.37	256.23	255.75	256.29
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022

9.8	8.2	5.3	18.9	11.8	45.41	29.23	138.07	60.57	43.27	38.26	62.41	64.63	65.17
14	11.9	6.8	8.6	12.1	12.89	15.26	21.01	24.46	28.97	24.04	23.39	23.96	25.48
0.2	0.3	0.2	0.6	0.9	0.73	3.25	1.67	1.62	7.86	4.61	3.66	7.38	4.06
0.2	0.2	0.2	0.4	0.4	0.65	0.85	1.06	1.28	1.36	1.34	1.66	1.43	1.36
0.2	0.4	0.4	0.6	1.9	2.35	2.98	2.39	2.5	3.42	13.88	12.78	2.42	11.69
24.4	21	12.9	29.1	27.1	62.02	51.57	164.2	90.42	84.87	82.13	103.89	99.82	107.76
0.8	2	4.3	6.1	7.6	8.41	9.56	13.29	13.06	12.72	16.09	16.43	16.4	14.42
0	14.5	15.1	19.2	33.3	72.14	78.2	13.35	14.43	14.9	22.73	11.54	18.71	10.88
17.4	21.1	22.9	24.3	39	45.98	153.12	64.72	67.3	67.59	69.81	68.25	66.57	63.6
0.1	0	0	0	1.8	1.94	2.55	6.68	5.82	6.38	5.68	4.56	31.54	3.46
0	0	0	0	0	0	0	8.01	7.7	27.88	27.74	27.41	0	26.99
0	0.2	0.2	11.7	11.7	0.21	37.97	0.33	0	0.15	0.1	1.14	0.67	0.89
18.3	37.8	42.5	61.3	93.4	128.68	281.4	106.38	108.31	129.61	142.14	129.33	133.89	120.23
42.7	58.8	55.4	90.4	120.5	190.71	332.96	270.57	198.73	214.48	224.27	233.22	233.71	228

25.7	25.7	25.7	53.5	53.5	96.66	96.66	96.67	96.67	96.38	95.99	95.65	95.16	94.69
0	0	0	0	0	0	0	0	0	0	0	0	0	0
1.3	7.4	15.9	18.1	25.1	50.32	77.7	51.94	41.82	44.21	51.62	55.47	54.56	51.93
0	0	-1	-0.5	-0.9	-1.61	-2.05	-8.09	-3.56	-3.92	-3.77	-3.95	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0
27	33.1	40.6	71.1	77.7	145.37	172.31	140.52	134.93	136.67	143.85	147.17	149.72	146.62
4.2	13.1	0.5	0.8	4.7	0.91	2.86	3.86	3.02	4.14	3.26	4.65	11.42	3.69
0.9	1.4	1.3	1.6	1.3	4.14	5.61	4.52	3.57	5.3	6.33	5.21	0	2.91
5.7	5.8	6.2	5.8	10.9	10.77	8.22	21.23	22.2	25.54	14.04	14.66	10.69	13.09
1.1	0.8	0	0	0	3.5	3.5	1.06	1.27	0	0	0	0	0
0	0	0.1	0.1	0.3	0.95	0.99	2.12	2.12	0.3	1.44	1.89	2.12	1.2
11.9	21.1	8.1	8.3	17.2	20.27	21.18	32.8	32.18	35.27	25.07	26.4	24.24	20.89
0	0	0.8	2.5	5.9	8.4	124.82	76.15	6.61	4.31	5.35	5.76	0.84	1.02
0	0	0.1	0.1	0.2	0.19	0.09	4.07	3.89	7.07	5.21	4.63	4.17	3.96
2.6	4.6	5.9	8.4	19.6	20.55	24.93	24.8	30.72	46.5	59.37	63.2	67.77	67.8
2.6	4.6	6.8	11	25.7	29.14	149.84	105.02	41.23	57.87	69.93	73.59	72.78	72.78
14.5	25.7	14.9	19.3	42.9	49.42	171.02	137.82	73.4	93.14	95	99.99	97.02	93.67
41.5	58.8	55.5	90.4	120.6	194.79	343.32	278.33	208.33	229.81	238.85	247.16	246.74	240.28

2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
7	9	9	7	14	31	33	13	-1	8	8	7	7	5	4
0	0	0	0	0	1	1	2	3	4	4	4	3	3	4
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-4	-1	0	-2	0	-7	-11	-5	0	-3	8	12	0	0	3
0	0	-1	0	-6	-22	-27	-14	2	1	-9	-8	0	-3	-4
0	0	0	0	0	0	3	5	2	0	0	0	0	0	0
0	1	1	1	0	1	1	1	0	1	3	0	0	1	1
3	8	8	6	8	3	-3	-4	4	10	11	15	9	5	7
0	-1	-3	-2	-1	-1	-2	-5	-1	-2	-2	-1	-1	-2	-2
-3	-16	-4	-20	-10	-9	-115	168	30	-9	4	-1	-23	4	-2
-2	-14	-1	-17	-8	-7	-112	174	32	-6	6	0	-22	6	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	1	3	6	115	-53	-71	-6	0	0	-3	0	0
0	0	0	29	0	0	-6	0	0	-6	0	0	0	0	0
1	9	-7	23	-3	30	101	-110	-78	-16	-12	-2	3	-11	0
1	9	-8	-3	0	0	-2	-20	-6	0	-10	0	9	-9	0
0	0	0	-4	-6	-5	-5	-36	0	-3	-1	-2	-2	-2	0
2	1	-3	8	-4	24	-16	53	-43	-15	3	11	-10	-2	5
3.38	6.72	4.98	3.62	6.76	1.82	-6.24	-9.77	2.35	7.41	9.55	14.53	7.93	3.55	5.11
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Cordlife Group 브루토마진	Cordlife Group 이익 마진	Cordlife Group EBIT-마진	Cordlife Group 이익 마진
2023	66.94 %	-0.79 %	6.32 %
2022	67.43 %	2.74 %	8.86 %
2021	69.67 %	8.65 %	10.83 %
2020	62.7 %	-10.86 %	12.93 %
2019	64.45 %	-4.75 %	10.51 %
2018	67.68 %	5.24 %	5.27 %
2017	64.75 %	1.37 %	-4.29 %
2016	66.18 %	2.79 %	20.68 %
2015	69.5 %	10.13 %	56.37 %
2014	71.01 %	18.36 %	62.18 %
2013	72.91 %	21.33 %	38.9 %
2012	70.96 %	18.48 %	22.77 %
2011	71.21 %	28.02 %	33.07 %
2010	72.7 %	29.79 %	29.43 %
2009	72.57 %	31.42 %	27.43 %

	브루토마진	EBIT-마진	이익 마진
2009	72.57 %	31.42 %	27.43 %
2010	72.7 %	29.79 %	29.43 %
2011	71.21 %	28.02 %	33.07 %
2012	70.96 %	18.48 %	22.77 %
2013	72.91 %	21.33 %	38.9 %
2014	71.01 %	18.36 %	62.18 %
2015	69.5 %	10.13 %	56.37 %
2016	66.18 %	2.79 %	20.68 %
2017	64.75 %	1.37 %	-4.29 %
2018	67.68 %	5.24 %	5.27 %
2019	64.45 %	-4.75 %	10.51 %
2020	62.7 %	-10.86 %	12.93 %
2021	69.67 %	8.65 %	10.83 %
2022	67.43 %	2.74 %	8.86 %
2023	66.94 %	-0.79 %	6.32 %

날짜	Cordlife Group 주당 매출	Cordlife Group EBIT 당 주식	Cordlife Group 주당 이익
2023	0.22 undefined	-0 undefined	0.01 undefined
2022	0.22 undefined	0.01 undefined	0.02 undefined
2021	0.22 undefined	0.02 undefined	0.02 undefined
2020	0.2 undefined	-0.02 undefined	0.03 undefined
2019	0.24 undefined	-0.01 undefined	0.03 undefined
2018	0.41 undefined	0.02 undefined	0.02 undefined
2017	0.23 undefined	0 undefined	-0.01 undefined
2016	0.23 undefined	0.01 undefined	0.05 undefined
2015	0.22 undefined	0.02 undefined	0.12 undefined
2014	0.19 undefined	0.04 undefined	0.12 undefined
2013	0.15 undefined	0.03 undefined	0.06 undefined
2012	0.18 undefined	0.03 undefined	0.04 undefined
2011	0.12 undefined	0.03 undefined	0.04 undefined
2010	0.13 undefined	0.04 undefined	0.04 undefined
2009	0.11 undefined	0.03 undefined	0.03 undefined

	주당 매출	EBIT 당 주식	주당 이익
2009	0.11 SGD	0.03 SGD	0.03 SGD
2010	0.13 SGD	0.04 SGD	0.04 SGD
2011	0.12 SGD	0.03 SGD	0.04 SGD
2012	0.18 SGD	0.03 SGD	0.04 SGD
2013	0.15 SGD	0.03 SGD	0.06 SGD
2014	0.19 SGD	0.04 SGD	0.12 SGD
2015	0.22 SGD	0.02 SGD	0.12 SGD
2016	0.23 SGD	0.01 SGD	0.05 SGD
2017	0.23 SGD	0 SGD	-0.01 SGD
2018	0.41 SGD	0.02 SGD	0.02 SGD
2019	0.24 SGD	-0.01 SGD	0.03 SGD
2020	0.2 SGD	-0.02 SGD	0.03 SGD
2021	0.22 SGD	0.02 SGD	0.02 SGD
2022	0.22 SGD	0.01 SGD	0.02 SGD
2023	0.22 SGD	-0 SGD	0.01 SGD

	주식 수량
2009	210.9 백만 Aktien
2010	210.9 백만 Aktien
2011	210.9 백만 Aktien
2012	171.7 백만 Aktien
2013	232.6 백만 Aktien
2014	256.59 백만 Aktien
2015	260.34 백만 Aktien
2016	259.77 백만 Aktien
2017	259.37 백만 Aktien
2018	254.29 백만 Aktien
2019	254.63 백만 Aktien
2020	256.37 백만 Aktien
2021	256.23 백만 Aktien
2022	255.75 백만 Aktien
2023	256.29 백만 Aktien

날짜	Cordlife Group 배당금
2022	0.01 undefined
2021	0.01 undefined
2020	0.01 undefined
2019	0 undefined
2018	0.01 undefined
2017	0.01 undefined
2015	0.15 undefined
2014	0.02 undefined
2013	0.02 undefined
2012	0.04 undefined

	배당금	배당금 (추정)
2009	0 SGD	0 SGD
2010	0 SGD	0 SGD
2011	0 SGD	0 SGD
2012	0.04 SGD	0 SGD
2013	0.02 SGD	0 SGD
2014	0.02 SGD	0 SGD
2015	0.15 SGD	0 SGD
2016	0 SGD	0 SGD
2017	0.01 SGD	0 SGD
2018	0.01 SGD	0 SGD
2019	0 SGD	0 SGD
2020	0.01 SGD	0 SGD
2021	0.01 SGD	0 SGD
2022	0.01 SGD	0 SGD
2023	0 SGD	0 SGD

날짜	Cordlife Group 배당률
2023	41.28 %
2022	47.1 %
2021	37.59 %
2020	39.15 %
2019	15.74 %
2018	36.76 %
2017	-50.4 %
2016	41.28 %
2015	120.31 %
2014	16.81 %
2013	33.33 %
2012	90 %
2011	41.28 %
2010	41.28 %
2009	41.28 %

	배당률
2009	41.28 %
2010	41.28 %
2011	41.28 %
2012	90 %
2013	33.33 %
2014	16.81 %
2015	120.31 %
2016	41.28 %
2017	-50.4 %
2018	36.76 %
2019	15.74 %
2020	39.15 %
2021	37.59 %
2022	47.1 %
2023	41.28 %

%-지분	이름	주식	변경
26.71114 %	TransGlobal Real Estate Group Limited	71,460,300	0
19.38848 %	Nanjing Xinjiekou Department Store Co. Ltd.	51,870,000	0
9.53787 %	Kang (Lan)	25,516,666	25,516,666
4.78451 %	Cedar Tree Investment Ltd	12,800,000	0
3.51626 %	China Minsheng Investment Group (CMIG)	9,407,060	-8,725,940
1.16137 %	Coop International Pte. Ltd.	3,107,000	0
0.95951 %	Tantalum Cellular Products LLC	2,566,972	0
0.43572 %	Tan (Poh Lan)	1,165,680	0
0.30095 %	Thet (Hnin Yi)	805,120	0
0.29606 %	Ho (Choon Hou)	792,061	0
0.18240 %	Kheng (May Lian Susan)	487,970	0
0.18211 %	Lee (In Chun)	487,200	0
0.16411 %	Chan (Cheng Lock)	439,050	15,000
0 %	Global Cord Blood Corp	0	-25,516,666

이름	관계	이주간 상관관계	원월 상관관계	삼개월 상관계수	여섯달 상관관계	일년간 상관관계
Global Cord Blood	공급업체고객	0,54	0,15	0,01	0,18
Eone Diagnomics Genome	공급업체고객	0,36	0,51	-0,04	0,36	0,26
Nanjing Xinjiekou A	공급업체고객	-0,04	-0,10			0,04

What values and corporate philosophy does Cordlife Group represent?

Cordlife Group Ltd represents a commitment to providing advanced cord blood and tissue banking services. Their corporate philosophy revolves around prioritizing the healthcare needs of families. Cordlife aims to offer secure storage for umbilical cord blood, which contains valuable stem cells that have potential therapeutic applications. They believe in empowering individuals and the medical community with access to these life-saving resources, helping to pave the way for advancements in regenerative medicine. Cordlife Group Ltd recognizes the importance of investing in technology and research to continually improve their services and contribute to the field of stem cell science.

In which countries and regions is Cordlife Group primarily present?

Cordlife Group Ltd is primarily present in several countries and regions. The company has a strong presence in Singapore, where it is headquartered. It is also actively operating in Hong Kong, India, Indonesia, Malaysia, and the Philippines. Cordlife Group Ltd has established cord blood banks and stem cell facilities in these countries, offering various services and products related to cord blood banking and umbilical cord stem cell preservation. With its extensive network and expertise, Cordlife Group Ltd continues to expand and provide reliable services to families seeking to store their newborn's cord blood for future medical use.

What significant milestones has the company Cordlife Group achieved?

Cordlife Group Ltd has achieved several significant milestones in its history. One of the notable achievements was the successful IPO listing on the Singapore Exchange Securities Trading Limited in 2011. This milestone not only demonstrated the company's strong market position but also opened up new opportunities for growth and expansion. Furthermore, Cordlife Group Ltd has consistently expanded its presence in the international market, establishing a strong foothold in countries like Hong Kong, India, and the Philippines. Additionally, the company has received several prestigious awards and recognition for its commitment to quality and excellence in stem cell banking services. These achievements have solidified Cordlife Group Ltd's position as a leading player in the industry.

What is the history and background of the company Cordlife Group?

Cordlife Group Ltd is a leading consumer healthcare group, dedicated to providing stem cell banking and cord blood services. Founded in 2001, Cordlife has a rich history of delivering high-quality stem cell banking solutions to families in Asia-Pacific. With a strong focus on innovation and research, Cordlife has established a reputation for its state-of-the-art laboratory facilities and commitment to exceptional service. As a pioneer in the field, Cordlife has successfully stored and preserved thousands of cord blood units, offering opportunities for future medical treatments and therapies. With a strong track record and a dedicated team of professionals, Cordlife Group Ltd continues to pave the way in the stem cell banking industry.

Who are the main competitors of Cordlife Group in the market?

The main competitors of Cordlife Group Ltd in the market are StemLife, Cryoviva, and Cryo-Save.

In which industries is Cordlife Group primarily active?

Cordlife Group Ltd is primarily active in the healthcare industry.

What is the business model of Cordlife Group?

Cordlife Group Ltd operates with a business model focused on providing cord blood banking and cord tissue banking services. As a leading consumer healthcare company, Cordlife Group offers expectant parents the opportunity to store their baby's umbilical cord blood and tissue, which contain potentially life-saving stem cells. These stem cells can be used in the future for various medical treatments, including cancer, blood disorders, and immune system disorders. Cordlife Group ensures that the collected stem cells are processed, tested, and stored under strict quality standards, ensuring their viability and safety for potential future use.

Cordlife Group 2024의 P/E 비율은 얼마입니까?

Cordlife Group에 대한 현재 주가 수익 비율을 계산할 수 없습니다.

Cordlife Group 2024의 KUV는 얼마입니까?

Cordlife Group에 대한 현재 KUV는 계산할 수 없습니다.

Cordlife Group의 AlleAktien 품질 점수는 얼마인가요?

Cordlife Group에 대한 AlleAktien 품질 점수는 2/10입니다.

Cordlife Group 2024의 매출은 얼마인가요?

Cordlife Group에 대한 현재 매출은 계산할 수 없습니다.

Cordlife Group 2024의 이익은 얼마인가요?

Cordlife Group의 현재 이익을 계산할 수 없습니다.

Cordlife Group은 무엇을 하나요?

Cordlife Group Ltd is a biotechnology company specializing in stem cell storage. The company offers various products and services tailored to the needs of families and medical professionals. Cordlife operates stem cell storage banks in various countries, including Australia, Hong Kong, India, Indonesia, Malaysia, Philippines, Singapore, and Thailand. The facilities are certified to the highest international quality standards and provide a safe and reliable solution for stem cell storage. The company offers various stem cell products, including umbilical cord blood, umbilical cord tissue, and placental tissue. These products can be used for various diseases and conditions, such as leukemia, sickle cell anemia, thalassemia, autism, cerebral palsy, and diabetes. Cordlife also offers services for the collection of umbilical cord blood and umbilical cord tissue. The company works with selected medical facilities to ensure safe and effective collection. Umbilical cord blood collection is a simple and non-invasive method that can be done during childbirth. Cordlife also has a research and development department focused on the development of new technologies and products. The company strives to constantly improve its services and provide innovative solutions to enhance the health and well-being of people worldwide. The business model of Cordlife Group Ltd is based on stem cell storage and providing products and services tailored to the needs of families and medical professionals. The company utilizes state-of-the-art technologies and facilities to ensure safe and effective storage and collection of stem cells. The company has a strong focus on research and development of new technologies and products to ensure it stays at the forefront of science. This allows the company to improve its services and offer innovative solutions to enhance the health and well-being of people worldwide. Cordlife Group Ltd has a strong presence in Asia and is constantly expanding into new regions and countries. The company works closely with medical facilities and professionals to continuously improve and optimize its services. In conclusion, Cordlife Group Ltd is a biotechnology company specializing in stem cell storage and provision of stem cell products and services. The company has a strong focus on research and development of new technologies and products to ensure it stays at the forefront of science. With its strong emphasis on quality and customer service, Cordlife Group Ltd is expected to remain a leading player in the biotechnology industry.

Cordlife Group 배당금은 얼마입니까?

Cordlife Group은(는) 연간 번의 배당을 통해 0.01 SGD의 배당금을 지급합니다.

Cordlife Group이 얼마나 자주 배당을 지급하나요?

Cordlife Group의 현재 배당금은 계산할 수 없거나, 회사가 배당금을 지급하지 않습니다.

Cordlife Group ISIN이 무엇입니까?

Cordlife Group의 ISIN은 SG2E64980112입니다.

Cordlife Group WKN은 무엇인가요?

Cordlife Group의 WKN은 A1JWVR입니다.

Cordlife Group 티커는 무엇인가요?

Cordlife Group의 티커는 P8A.SI입니다.

Cordlife Group이 얼마만큼의 배당금을 지급합니까?

지난 12개월 동안 Cordlife Group은(는) 0.01 SGD 의 배당금을 지급했습니다. 이는 약 6 %의 배당 수익률에 해당합니다. 향후 12개월 동안 Cordlife Group은(는) 0.01 SGD의 배당금을 지급할 것으로 예상됩니다.

Cordlife Group의 배당 수익률은 얼마입니까?

Cordlife Group의 현재 배당 수익률은 6 %입니다.

Cordlife Group의 배당금은 언제 지급되나요?

Cordlife Group은 분기별로 배당금을 지급합니다. 이는 , , , 월에 배당됩니다.

Cordlife Group의 배당금은 얼마나 안전한가요?

Cordlife Group은(는) 지난 0년 동안 매년 배당금을 지급했습니다.

Cordlife Group의 배당금은 얼마입니까?

향후 12개월 동안 0.01 SGD의 배당금이 예상됩니다. 이는 배당수익률 6 %에 해당합니다.

Cordlife Group이(가) 속해 있는 섹터는 어디인가요?

Cordlife Group은 '건강' 섹터에 속합니다.

Wann musste ich die Aktien von Cordlife Group kaufen, um die vorherige Dividende zu erhalten?

Cordlife Group의 마지막 배당금을 0.009 SGD만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

Cordlife Group의 마지막 배당금 지급일은 언제였습니까?

마지막 배당금 지급일은 입니다.

Cordlife Group의 2023년도 배당금은 얼마였습니까?

2023년에 Cordlife Group는 0.009 SGD를 배당금으로 지급했습니다.

Cordlife Group는 어떤 화폐로 배당금을 지급하나요?

Cordlife Group의 배당금은 SGD에 지급됩니다.

Cordlife Group 티커	Cordlife Group FIGI
CLGL:SP	BBG002QJRSW9
CLIFF:US	BBG003M7JPR8
CLIFF:PQ	BBG003M7JQ50
CLIFF:UV	BBG003M7JQ78
CLGLSGD:XH	BBG00ZV6NKR5
CLGLSGD:XF	BBG00ZV6NKT3
CLGLSGD:XE	BBG00ZV6NKW9
CLGLSGD:XL	BBG00ZV6NKY7
CLGLSGD:XG	BBG00ZV6NKZ6
CLGLSGD:XO	BBG00ZV6NL02
CLGLSGD:XA	BBG00ZV6NL48
CLGLSGD:XT	BBG00ZV6NL66
CLGLSGD:XW	BBG00ZV6NL75
CLGLSGD:XU	BBG00ZV6NL84
CLGLSGD:XV	BBG00ZV6NLB0
CLGLSGD:XM	BBG00ZV6NLC9
CLGLSGD:EU	BBG00ZV6NLL9

한 눈에 저평가된 주식을 인식하세요

가격

가격

티커P8A.SI

ISINSG2E64980112

WKNA1JWVR

Cordlife Group 주식 가격

가격

개요

인트라데이 기능

총 수익률 및 상대 가격 변동

해석 및 투자

Cordlife Group 주가 이력

Cordlife Group 주식 매출, EBIT, 이익 SG2E64980112 · A1JWVR

매출, 이익 & EBIT

매출, EBIT, 소득 이해하기

연간 분석 및 비교

투자 기대치 활용

투자 통찰력

Cordlife Group 매출, 이익 및 EBIT 역사

Cordlife Group 주식 지표

손익계산서

매출 성장

총 이익률

EBIT와 EBIT 마진

수입과 성장

발행 주식

연간 비교의 해석

기대치와 예측

재무 상태표

재무 상태표 이해

자산

부채

자본

년대비 분석

데이터 해석

Cordlife Group 주식 마진 SG2E64980112 · A1JWVR

마진

매출 총이익률 이해

EBIT 마진 분석

매출 마진에 대한 인사이트

기대치 해석

비교 분석

Cordlife Group 마진 역사

Cordlife Group 주식 매출, EBIT, 주당 순이익 SG2E64980112 · A1JWVR

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

Cordlife Group 매출, 이익 및 EBIT 주당 역사

Cordlife Group 주식 및 주식 분석

한눈에 과소평가된 주식을 인식하세요.

Cordlife Group Fair Value에 따른 평가

Fair Value

Fair Value 이해하기

수익 기반 Fair Value

매출 기반 Fair Value

배당 기반 Fair Value

기대치와 예측

비교 분석

Cordlife Group 역사적인 P/E, EBIT 및 P/S에 따른 평가

한눈에 과소평가된 주식을 인식하세요.

Cordlife Group 주식 수량 SG2E64980112 · A1JWVR

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

Cordlife Group 주식 배당금 SG2E64980112 · A1JWVR

배당금

배당금에 대한 개요

해석 및 사용

투자 전략

Cordlife Group 배당금 내역

Cordlife Group 주식 배당률 SG2E64980112 · A1JWVR

배당비율

연간 배당비율이란 무엇인가요?

데이터 해석 방법

투자에 대한 데이터 사용

티커
P8A.SI

ISIN
SG2E64980112

WKN
A1JWVR